// App-Quantinova.ai

e15701 : The fibrinogen/CRP ratio as a novel prognostic parameter for pancreatic cancer patients.

Researchers

Presenter

  • Thomas Winder

Principal Investigators

  • Michael Stotz

  • Alexander Rheinhard Siebenhuener

  • Konstantin Schlick

  • Teresa Magnes

  • Panagiotis Samaras

  • Joanna Szkandera

  • Pierre-Alain Clavien

  • Daniel Neureiter

  • Richard Greil

  • Bernhard C. Pestalozzi

  • Armin Gerger

  • Alexander Egle

  • Martin Pichler

Medical Centers

  • University Hospital of Zurich, Zurich, Switzerland

  • Division of Clinical Oncology, Department of Internal Medicine, Medical University Graz, Graz, Austria

  • University Hospital of Zurich, Zurich, Switzerland

  • IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Salzburg, Austria

  • Institute of Pathology, Salzburg, Austria

  • Paracelsus Medical University Salzburg, Salzburg, Austria

  • Medical University Graz, Graz, Austria

  • University Hospital Salzburg, Salzburg, Austria

  • Medical University of Graz, Division of Oncology, Graz, Austria

Locations

  • Switzerland

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

  • Solid malignancies

Biomarkers

  • C reactive protein

Drug/Treatment

  • Fibrinogen (IV)

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved